Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Department of the Treasury
Manufacturing
Bipartisan bill targets foreign drugmaking in US
Although the bill does not single out any specific country, at least one of its three co-sponsors has one name in mind: China.
Angus Liu
Jul 16, 2026 11:27am
Fierce Biotech
Will COINS Act kill China biotech licensing boom?
May 26, 2026 3:50pm
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
Sep 14, 2021 4:00pm
AbbVie, Shire investors settle lawsuit over scuttled merger
Apr 12, 2019 11:50am
Brace yourself, pharma: Tax inversions could return
Apr 24, 2017 11:22am
